| Literature DB >> 31572080 |
Semagn Mekonnen Abate1, Akine Eshete Belihu2.
Abstract
Hypotension during spinal Anesthesia is the most common complication with maternal and neonatal morbidity and mortality. Low dose bupivacaine with intrathecal fentanyl is recommended as strategy to prevent spinal Anesthesia induced hypotension and related complications. The aim of this systemic review is to evaluate the efficacy of low dose bupivacaine with Intrathecal fentanyl on the improvement of maternal and neonatal outcomes compared to conventional dose bupivacaine among mothers who undergone cesarean section. We conducted a systemic search of the electronic databases of Pubmed, Medline, LILACS and others with PICO strategy for randomized controlled clinical trials comparing low dose bupivacaine with fentanyl and conventional dose bupivacaine for cesarean section. Joanna Briggs Institute (JBI) standardized data extraction form was used for data extraction and finally entered into Review Manager for data synthesis. Ten Randomized trials (552) were included in this review. Incidence of hypotension was less likely in mothers who received low dose bupivacaine with Fentanyl as compared to those with conventional dose of bupivacaine alone (RR = 0.43, 95% confidence interval (CI) 0.12-0.47, ten trials, 552 participants). The review revealed that Low dose bupivacaine combined with intrathecal Fentanyl decrease incidence of hypotension. Copyright:Entities:
Keywords: Bupivacaine; cesarean section; hypotension; spinal Anesthesia
Year: 2019 PMID: 31572080 PMCID: PMC6753776 DOI: 10.4103/sja.SJA_17_19
Source DB: PubMed Journal: Saudi J Anaesth
Study Eligibility Assessment Tool
| S. No. | Parameters | Assessment | Comment | ||
|---|---|---|---|---|---|
| Yes | Unclear | No | |||
| 1 | Is the study described as randomized? (Excluding cross over and Quasi-experiment) | ||||
| 2 | Were participants diagnosed as patients with disease of interest? | ||||
| 3 | Were inclusion and exclusion criteria described? | ||||
| 4 | Was the ethical review described? | ||||
| 5 | Were participants of the prespecified age? Yes, if ages are mixed as < and > but not only one | ||||
| 6 | Were comparison groups treated with prespecified intervention in one group and control intervention in other group? | ||||
| 7 | Did the study report prespecified outcomes? | ||||
| 8 | Was the full article accessible or available? | ||||
| 9 | Was appropriate statistical used? | ||||
FINAL DECISION: Any parameter with ‘NO’ value will be excluded. Adapted from Cochrane-Handbook of systemic Reviews, 201
Description of included studies
| Study | Sample size | Comparison | Spinal technique | Analgesic/vasopressor/supplementation | Efficacy criteria |
|---|---|---|---|---|---|
| Bruce and colleague | 32 | IB 0.5% 5 mg B + 15 mg F; 10 mg B alone | Sitting position | Ephedrine was provided for | Pain assessment; sensory block T4,5 |
| Gajbhare and colleague | 60 | HB 0.5% 8 mg + 20 mg F ; HB 10 mg B | Left lateral with UD | Mephenteramine was provided | Pain assessment; sensory block T5 |
| Gandam and colleagues | 50 | HB 0.5% 7.5 mg B + 25 mg F; 10 mg B alone | Not available | N/a | Pain assessment; sensory block T6 |
| Gauchan and colleagues | 70 | HB 0.5% 10 mg B + 20 mg F; 12 mg B alone | Sitting position | N/a | Pain assessment; sensory block T4 |
| Manowarul and colleagues | 90 | HB 0.5% 8.5 mg B + 25 mg F; HB 0.5% 8.5 mg + 75 mg cl; HB 0.5% 10 mg B + placebo | Sitting position | More ephedrine required for B group alone | Pain assessment; sensory block T4 |
| Mohammed and colleagues | 60 | HB 0.5% 7.5 mg B + 25 mg F; 10 mg B alone | LLD with UD | N/a | Pain assessment; sensory block T8 |
| Nasir and colleagues | 60 | HB 0.5% 8 mg B + 25 mg F; 12.5 mg B alone | Sitting position | Ephedrine was used | Pain assessment; sensory block T4 |
| Selima and colleagues | 40 | HB 0.5% 4 mg B + 25 mg F; 10 mg B alone | Sitting position | Ephedrine dose was higher in B, fentanyl | Pain assessment; sensory block T6 |
| Sheikh and colleagues | 50 | HB 0.5% 10 mg B + 12.5 mg F; 10 mg B with placebo | Sitting position | N/a | Pain assessment; sensory block T5 |
| Seyedhejazi and colleagues | 40 | HB 0.5% 8 mg B + 25 mg F; 12 mg B alone | Sitting position | Ephedrine was used | Pain assessment; sensory block T4-5 |
HB: Hyperbaric; IB: Isobaric Bupivacaine; B: Bupivacaine; F: Fentanyl; RLD: Right Lateral Decupitus; LLD: Left Lateral Decupitus; UD: Uterine Displacement; N/a: Not Available
Descriptions of excluded studies
| Study | Publication Year | Sample size | Reason for exclusion |
|---|---|---|---|
| Ahmed and colleagues | 2012 | 172 | Comparison was bupivacaine with fentanyl for the each groups |
| Atanas and colleagues | 2009 | 60 | Comparison was bupivacaine with fentanyl for the each groups |
| Canaan and colleagues | 2012 | 40 | Comparison was bupivacaine and levobupivacaine with fentanyl for each group |
| Kajal and colleagues | 2013 | 24 | Comparison was bupivacaine with fentanyl for the each groups |
| Maqsood and colleagues | 2017 | 90 | Low and high bupivacaine dose without Adjuvant |
| Mhamed and colleagues | 2010 | 80 | Comparison was bupivacaine with fentanyl and morphine |
| Moshir and colleagues | 2017 | 60 | Low and high bupivacaine dose without Adjuvant |
| Sachi and colleagues | 2015 | 60 | Comparison was for orthopedic elderly patients |
| Subisa and colleagues | 2012 | 80 | Comparison was bupivacaine and levobupivacaine with fentanyl for each group |
| Vankateswara and colleagues | 2015 | 120 | Comparison three groups with low dose bupivacaine and fentanyl for each |
Figure 1PRISMA flow diagram
Risk of Bias within studies
| Study | Sequence generation | Allocation concealment | Blinding | Incomplete Outcome data | Selective Outcome reporting | Free of other bias | Jadad scale | ||
|---|---|---|---|---|---|---|---|---|---|
| randomization | Blinding | Withdrawal | |||||||
| Bruce and colleague | C | A | C | A | A | A | 2 | 0 | 0 |
| Gajbhare and colleague | A | A | C | A | A | A | 2 | 0 | 0 |
| Gandam and colleagues | C | C | A | A | A | A | 2 | 2 | 0 |
| Gauchan and colleagues | C | A | A | A | A | A | 2 | 2 | 0 |
| Manowarul and colleagues | C | C | C | A | A | A | 1 | 1 | 0 |
| Mohammed and colleagues | C | C | A | A | A | A | 2 | 2 | 0 |
| Nasir and colleagues | C | C | C | A | A | A | 2 | 2 | 0 |
| Selima and colleagues | A | C | A | A | A | A | 2 | 2 | 0 |
| Sheikh and colleagues | C | C | C | A | A | A | 1 | 1 | 0 |
| Seyedhejazi and colleagues | A | A | A | A | A | A | 2 | 2 | 0 |
A: low risk; B: High risk; C: uncertain/unclear risk of bias. Jadad scale: 2- double; 1-single; 0-no blind at all or withdrawal
Prisma statement checklist
| Section/topic | Number | Checklist item | Page |
|---|---|---|---|
| Title | 1 | Efficacy of low dose Bupivacaine with Intrathecal fentanyl for cesarean section on maternal hemodynamic: systemic Review and Meta-analysis | 1 |
| Structured summary | 2 | Background: Hypotension during spinal anesthesia is the most common complication which is associated with maternal and neonatal morbidity and mortality. Objective: The aim of this systemic review is to compare low dose bupivacaine with intrathecal fentanyl and conventional dose bupivacaine for ASA I and II term pregnant mother for elective cesarean section. Methods: We conducted a systemic search of the electronic databases of Pubmed, Medline, LILACS and others with PICO strategy for randomized controlled clinical trials comparing low dose bupivacaine with fentanyl and conventional dose bupivacaine for cesarean section. Eligibility assessment was performed independently by the two review authors using a customized form, while discrepancies were resolved by consensus. The Data from individual randomized clinical trial were extracted and entered Review Manager for synthesis. Results: Incidence of hypotension was less likely in mothers who received low dose bupivacaine with fentanyl as compared to those with conventional dose of bupivacaine alone (RR=0.43, 95% confidence interval (CI) 0.12-0.47, ten trials, 552 participants). Conclusion: The review revealed that low dose bupivacaine combined with intrathecal fentanyl decrease incidence of hypotension and associated complications despite Pruritus which is self-limiting without significant morbidity | 2 |
| Rationale | 3 | High dose bupivacaine provides sensory and motor block but associated with high incidence of hypotension and maternal and poor neonatal outcomes. On the other hand, low dose bupivacaine (<8 mg) is associated with inadequate anesthesia despite low incidence of hypotension. Low dose bupivacaine with fentanyl provides adequate anesthesia with stable maternal hemodynamic and neonatal outcomes. However, there are discrepancies on efficacy of low dose bupivacaine and fentanyl. Therefore, we conducted this systemic review and meta-analysis to assess efficacy of low dose bupivacaine with intrathecal fentanyl | 3 |
| Objectives | 4 | The aim of this systemic review is to compare low dose bupivacaine with intrathecal fentanyl and conventional dose bupivacaine for ASA I and II term pregnant mother for elective caesarean section | 4 |
| Protocol and registration | 5 | Protocols of individual trials were checked | 5 |
| Eligibility criteria | 6 | Term ASA I and II pregnant women scheduled for elective caesarean section and followed for 24 hrs perioperatively | 5 |
| Information sources | 7 | The electronic databases of Pubmed, Medline, LILACS and others with PICO strategy for randomized controlled clinical trials comparing low dose bupivacaine with fentanyl and conventional dose bupivacaine for cesarean section were searched without date and language restriction | 6 |
| Search | 8 | The electronic databases of Pubmed, Medline, LILACS and others with PICO strategy for randomized controlled clinical trials comparing low dose Bupivacaine with fentanyl and conventional dose bupivacaine for cesarean section were searched without date and language restriction as shown below with medical subject heading (MeSH) terms of parturient, hemodynamic stability, pain, nausea and vomiting, spinal anesthesia were searched as follows: | 5 |
| Study selection | 9 | The author has chosen appropriate trials from those identified by the search strategy and retrieved the full articles and duplicate publications from the same data set were only used once. The two authors autonomously evaluated each article for inclusion in the review using the information described in the section criteria for considering studies for this review. The two authors independently assessed the methodological quality of the included trials which were measured by Generation of allocation sequence, allocation concealment, blinding and loss to follow up. For all trials, each quality component apart from blinding was classed as adequate, inadequate or unclear. For loss to follow up, inclusion of 90% of participants was considered adequate. Blinding was assessed using the following criteria: blinding of participants, blinding of health care providers and blinding of outcome assessment. | 7 |
| Data collection process | 10 | Data extraction was done by two authors. Trials that had similar methods of reporting outcomes (mean, proportion, etc.) were taken for meta-analysis data extraction. For trials that did not report the outcomes, the authors were contacted through email. | 7 |
| Data items | 11 | No special data items to be described and defined as it has been described in methodology. | |
| Risk of bias in individual studies | 12 | Risk of bias was assessed with independently as described in #9 | 7 |
| Summary measures | 13 | The main summary measures were relative risk, odd ratio, and mean difference | 7 |
| Synthesis of results | 14 | Synthesis of results was carried out with review manager. Heterogeneity of results between studies were quantified with I squared where I2 50% is taken as a substantial heterogeneity and source of heterogeneity were assessed with subgroup analysis and regression analysis. | 7 |
| Risk of bias across studies | 15 | We tried to assess publication bias with funnel plot and we did not see that much publication bias as shown with Egger’s test | 7 |
| Additional analyses | 16 | Subgroup analysis was done to find out source of heterogeneity (dose of bupivacaine (<8 and >8 mg), baricity, and patient position during injection) | 11 |
| Study selection | 17 | There were about 811 randomized trials identified from different databases as described in methodology section. There were about 20 trials that were selected for evaluation after successive screening. About 10 trials with 552 participants were included for final analysis and the rest were excluded with reasons | 8 |
| Study characteristics | 18 | Population sizes ranged from 32 to 90. Power analysis was mentioned in two studies and the variables considered for calculations were ephedrine requirements and duration of analgesia. The included clinical trials were published from 2000 up to 2017. The mean age of the patients included ranged from 24 to 37 year where as the mean weight reported was between 58 and 62 kg The majority of trials reported an appropriate method of randomization (1-3, 5-9). | 8 |
| Risk of bias within studies | 19 | It has been mentioned on Table 3 | |
| Results of individual studies | 20 | It has been mentioned on the figures | |
| Synthesis of results | 21 | Incidence of hypotension was less likely in mothers who received low dose bupivacaine with fentanyl as compared to those with conventional dose of bupivacaine alone (RR/OR=0.43, 95% confidence interval (CI) 0.12-0.47, ten trials, 552 participants). Incidence of Pruritus was thirteen times more likely in low dose bupivacaine with fentanyl (OR/RR=12.60, 95% confidence interval CI) 3.56 to 44.61, 5 trials, 290 participants) | 11 |
| Risk of bias across studies | 22 | Risk of bias was tried to be addressed with funnel plot but we did not present the graph | |
| Additional analysis | 23 | Table 10 was about subgroup analysis | |
| Summary of evidence | 24 | Low dose bupivacaine combined with fentanyl provides adequate analgesia without compromising maternal neonatal outcomes which in turn brings about cost effective patient care with high patient satisfaction and early discharge from the hospital. | 12 |
| Limitations | 25 | Data combing for pooled analysis was difficult as there was dissimilarity in reporting of some outcome variables | 12 |
| Conclusions | 26 | The finding of the pooled analysis was in consistent with the majority of included studies but the cut point for low dose bupivacaine is variable which varies from 4 mg to 10 mg. | 13 |
| Funding | 27 | Authors own resources | |
Figure 2Forest plot for incidence of hypotension low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis. Events: the total numbers with the events. Total: the total number of participants in intervention and control. Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. M–H, Mantel–Haenszel methods
Figure 3Forest plot for mean intraoperative systolic blood pressure comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis total: the total number of participants in intervention (BF) and control (B). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. IR: Inverse Variance
Figure 4Forest plot for mean intraoperative diastolic blood pressure comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis total: the total number of participants in intervention (BF) and control (B). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. IR: Inverse Variance
Figure 5Forest plot for incidence of nausea/vomiting comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis. Events, the total numbers with the events total: the total number of participants in intervention (SA) and control (GA). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. M–H, Mantel–Haenszel methods
Figure 6Forest plot for time to sensory block comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis. Total: the total number of participants in intervention (BF) and control (B). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. IR: Inverse Variance
Figure 7Forest plot for time to two segment regression comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis. Total: the total number of participants in intervention (BF) and control (B). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. IR: Inverse Variance
Figure 8Forest plot for complete sensory recovery comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis total: the total number of participants in intervention (BF) and control (B). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. IR: Inverse Variance
Figure 9Forest plot for complete motor recovery comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis total: the total number of participants in intervention (BF) and control (B). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. IR: Inverse Variance
Figure 10Forest plot for Incidence of adverse effects comparing low dose bupivacaine-fentanyl vs bupivacaine alone: individual trials and meta-analysis. Events, the total numbers with the events total: the total number of participants in intervention (SA) and control (GA). Weight: sample size contribution of the study relative to the pooled sample size of the meta-analysis. M–H, Mantel–Haenszel methods